An evidence-based ordering algorithm for appropriate utilization of peripheral blood flow cytometry for hematologic neoplasms
Am J Clin Pathol · 2026
DOI: 10.1093/ajcp/aqaf152 ↗Kurz gefasst
Fachartikel in der Zeitschrift Am J Clin Pathol, 2026. Verfasst von Anna Dar und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN, United States. Hauptthemen laut MEDLINE: Flow Cytometry, Algorithms, Hematologic Neoplasms. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
Although peripheral blood flow cytometry (PBFC) can aid in the diagnosis of hematolymphoid malignancies, it is often ordered in clinical situations for which it is not useful. We hypothesized that patient clinical data could be used to design an algorithm to guide better test utilization and performance.
Methods
Patient records for 250 consecutive PBFC orders were reviewed to determine test indication, patient demographics and history, blood count, and leukocyte differential. These variables were analyzed to determine whether they could predict the detection of hematolymphoid malignancy. Using these data, a test ordering algorithm was designed to maximize positive and minimize negative results, which was then validated on an additional set of 250 consecutive cases.
Results
Peripheral blood flow cytometry was infrequently positive for most indications. The presence of circulating blasts, history of hematolymphoid malignancy, and lymphocytosis or pancytopenia in patients 50 years of age and older are most predictive of positive results. Application of an algorithm incorporating these criteria would substantially reduce PBFC utilization while increasing the fraction of positive cases. Similar results were seen when the algorithm was applied to an independent validation set.
Conclusions
An evidence-based algorithm for ordering PBFC based on 5 clinical factors can substantially reduce utilization and increase positive results.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN, United States.
Zitieren
APA
Dar, A., & Seegmiller, A. C. (2026). An evidence-based ordering algorithm for appropriate utilization of peripheral blood flow cytometry for hematologic neoplasms. Am J Clin Pathol. https://doi.org/10.1093/ajcp/aqaf152
Vancouver
Dar A, Seegmiller AC. An evidence-based ordering algorithm for appropriate utilization of peripheral blood flow cytometry for hematologic neoplasms. Am J Clin Pathol. 2026. doi:10.1093/ajcp/aqaf152
BibTeX
@article{Dar2026,
author = {Dar, Anna and Seegmiller, Adam C},
title = {An evidence-based ordering algorithm for appropriate utilization of peripheral blood flow cytometry for hematologic neoplasms},
journal = {Am J Clin Pathol},
year = {2026},
doi = {10.1093/ajcp/aqaf152}
}
EUVIMED